Downregulation of the CCAAT-Enhancer Binding Protein β in ΔFosB Transgenic Mice and by Electroconvulsive Seizures

Neuropsychopharmacology

Volumn 29, Issue 1, 2004, Pages 23-31

  Chen, Jingshan ^a,c   Newton, Samuel S ^a   Zeng, Ling ^a   Adams, David H ^a   Dow, Anthoni L ^a   Madsen, Torsten M ^a   Nestler, Eric J ^b   Duman, Ronald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

FosB; Antidepressant; C EBP ; Hippocampus; Memory; Microarray

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; ISOPROTEIN; MESSENGER RNA; PROTEIN FOS;

ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DNA MICROARRAY; DOT HYBRIDIZATION; DOWN REGULATION; ELECTROCONVULSIVE THERAPY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DOWN-REGULATION; ELECTROSHOCK; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0346688567     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300289     Document Type: Article

References (38)

1. Alberini CM, Ghirardi M, Metz R, Kandel ER (1994). C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76: 1099-1114.
2. Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E et al (2001). Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem 79: 221-224.
3. Carew TJ, Sutton MA (2001). Molecular stepping stones in memory consolidation. Nat Neurosci 4: 769-771.
4. Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS (2001). Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49: 753-762.
5. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ (1997). Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci 17: 4933-4941.
6. Chen J, Kelz MB, Zeng G, Sakai N, Steffen C, Shockett PE et al (1998). Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol 54: 495-503.
7. Chen J, Zhang Y, Kelz MB, Steffen C, Ang ES, Zeng L et al (2000). Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB. J Neurosci 20: 8965-8971.
8. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002). cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22: 3262-3268.
9. Dowlatshahi D, MacQueen GM, Wang JF, Young LT (1998). Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352: 1754-1755.
10. D'Sa C, Duman RS (2002). Antidepressants and neuroplasticity. Bipolar Disord 4: 183-194.
11. Duman RS (2002). Synaptic plasticity and mood disorders. Mol Psychiatry 7: S29-S34.
12. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
13. Duman RS, Malberg J, Nakagawa S (2000). Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48: 732-739.
14. Franco-Bronson K (1996). The management of treatment-resistant depression in the medically ill. Psychiatr Clin N Am 19: 329-350.
15. Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA et al (1998). Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci 18: 6952-6962.
16. Hope BT, Kelz MB, Duman RS, Nestler EJ (1994). Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 14: 4318-4328.
17. Kelz MB, Chen J, Carlezon Jr WA, Whisler K, Gilden L, Beckmann AM et al (1999). Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401: 272-276.
18. Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB (2002). Changes in CREB-phosphorylation during recovery from major depression. J Psychiatr Res 36: 369.
19. Lekstrom-Himes J, Xanthopoulos KG (1998). Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273: 28545-28548.
20. Manji HK, Duman RS (2001). Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 35: 5-49.
21. Manji H, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nat Med 7: 541-547.
22. McKnight SL (2001). McBindall - a better name for CCAAT/enhancer binding proteins? Cell 107: 259-261.
23. Nakabeppu Y, Nathans D (1991). A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64: 751-759.
24. Nakabeppu Y, Oda S, Sekiguchi M (1993). Proliferative activation of quiescent Ra-1A cells by delta FosB. Mol Cell Biol 13: 4157-4166.
25. Nakagawa S, Kim JE, Lee R, Chen J, Fujioka T, Malberg J et al (2002), Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 22: 9868-9876.
26. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
27. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25.
28. Nestler EJ, Kelz MB, Chen J (1999). DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res 835: 10-17.
29. Newton SS, Chen J, Duman RS (2001). Microarray analysis of gene expression in mCREB inducible transgenic mice. Soc Neurosci Abstr 31: 113.
30. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
31. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365-2372.
32. Patel PD, Lopez JF (2001). Regulation of hippocampal CCAAT/enhancer binding protein BETA (C/EBP) mRNA in rats by antidepressant medications. Soc Neurosci Abstr 31: 22.
33. Ramji DP, Foka P (2002). CCAAT/enhancer-binding proteins: structure, function and regulation. J Biochem 365: 561-575.
34. Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L et al (1998). Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci USA 95: 10908-10913.
35. Stewart CA, Reid IC (2000). Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl) 148: 217-223.
36. Taubenfeld SM, Milekic MH, Monti B, Alberini CM (2001). The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta. Nat Neurosci 4: 813-818.
37. Thome J, Sakai BM, Shin KH, Steffen C, Zhang Y-J, Impey S et al (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20: 4030-4036.
38. Winston S, Hayward MD, Nestler EJ, Duman RS (1990). Chronic electroconvulsive seizures down regulate expression of the c-fos and c-jun proto-oncogenes in rat cerebral cortex. J Neurochem 54: 1920-1925.